The adoption of AI in clinical trials holds the potential to revolutionize how therapies are discovered, but the pace of that ...

("VDYNE" or "the Company"), a privately held medical device company developing next generation transcatheter valve replacement technologies, today announced that the U.S. Food & Drug Administration ...

Researchers have demonstrated laboratory and simulator proof-of-concept designs for battery-free knee-implant sensing that ...

A friendly debate held at the European Hematology Association 2023 Congress focused on the potential for real-world data to improve the generalizability of clinical trial results but also acknowledged ...

The evolution of clinical trials shows that although much has changed, several things remain the same. When a patient expresses interest in a trial, they complete an informed consent process, and ...

This randomized controlled trial involving subjects with asymptomatic, very severe aortic stenosis demonstrated that over a ...

Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.

A recombinant replacement for the ADAMTS13 protein (Adzynma) missing in congenital thrombotic thrombocytopenic purpura (TTP) restored levels and reduced acute TTP events, according to interim trial ...